Skip to content
Universidad del Mar SIBUMAR Descubridor Institucional UMAR
  • Inicio
  • Búsqueda avanzada
  • Explorar
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
Cover Image

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma

Fuente: Redalyc
Saved in:
Bibliographic Details
Main Author: Leticia García-Mochón
Format: Artículo científico
Language:en
Published: Sociedad Española de Farmacia Hospitalaria 2019
Subjects:
Medicina
Costs
Omalizumab
Mepolizumab
Budgetary impact
Economic assessment
Online Access:
Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
  • Holdings
  • Description
  • Comments
  • Similar Items
  • Staff View

Internet

https://www.redalyc.org/articulo.oa?id=365963307005
https://www.redalyc.org/journal/3659/365963307005/
https://www.redalyc.org/journal/3659/365963307005/html/
https://www.redalyc.org/journal/3659/365963307005/365963307005.epub
https://www.redalyc.org/journal/3659/365963307005/movil

Similar Items

  • Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of patients infected with HIV-1
    by: Itziar Oyagüez
    Published: (2009)
  • The relationship between cost management knowledge and budgetary participation with managers’ performance
    by: Alexandre Corrêa dos Santos
    Published: (2014)
  • Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma
    by: M. Pereira Barbosa
    Published: (2015)
  • Valuation of Environmental Assets in the Lake Victoria basin.
    by: Kulindwa, K.A.A.
    Published: (2006)
  • Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases
    by: María García
    Published: (2019)
Universidad del Mar
Universidad del MarSistema Bibliotecario de la Universidad del MarDescubridor Institucional UMARImplementación y desarrollo: Mtro. Carlos Alonso Albores Pérez
InicioBúsqueda avanzadaExplorar
Visitas al Descubridor: 33,245© 2026 Universidad del Mar